Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2019 Volume 18 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2019 Volume 18 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax

Retraction in: /10.3892/etm.2024.12771
  • Authors:
    • Liang Zhang
    • Jian Zhang
    • Qiguang Tong
    • Guannan Wang
    • Hongling Dong
    • Zhonglu Wang
    • Qi Sun
    • Hangyu Wu
  • View Affiliations / Copyright

    Affiliations: Heart Center, Beijing Chest Hospital, Capital Medical University, Beijing 101149, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1729-1737
    |
    Published online on: July 1, 2019
       https://doi.org/10.3892/etm.2019.7722
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The current study mainly aimed to evaluate the expression and the potential mechanism of miR‑29a‑3p in the hearts of mice after cardiac ischemia reperfusion (CIR) injury. Quantitative PCR was carried out to assess the relative levels of miR‑29a‑3p in the hearts of a CIR injury mouse model. To the best of our knowledge, the current study is the first to show that the level of miR‑29a‑3p was significantly decreased in the hearts of CIR injury mouse models compared with that of sham controls. Moreover, the authors found that decreased miR‑29a‑3p levels enhanced the production of reactive oxygen species in cardiomyocytes. Meanwhile, the inhibition of miR‑29a‑3p induced substantial cardiomyocyte apoptosis. Further study showed that the inhibition of miR‑29a‑3p decreased the activation of Akt and p38, suggesting a stress‑induced self‑regulatory mechanism after CIR injury in primary cardiomyocytes. A dual luciferase assay and western blot analysis showed that Bax was a target gene of miR‑29a‑3p. The authors also measured the level of miR‑29a‑3p in the plasma of 100 acute myocardial infarction (AMI) patients and found that circulating miR‑29a‑3p was significantly decreased in AMI patients. Receiver operating characteristic curve analysis showed that miR‑29a‑3p could be used to screen AMI patients from healthy controls. Hence, the authors of the current study propose that reduced miR‑29a‑3p levels in primary cardiomyocytes contribute to CIR injury‑related apoptosis mainly by targeting Bax.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Wu A, Zhao M, Lou L, Zhai J, Zhang D, Zhu H, Gao Y, Shang H and Chai L: Effect of Wenxin granules on gap junction and miR-1 in rats with myocardial infarction. Biomed Res Int. 2017:34950212017. View Article : Google Scholar : PubMed/NCBI

2 

Lin J and Zheng X: Salvianolate blocks apoptosis during myocardial infarction by down regulating miR-122-5p. Curr Neurovasc Res. 14:323–329. 2017. View Article : Google Scholar : PubMed/NCBI

3 

Yan Y, Song X, Li Z, Zhang J, Ren J, Wu J, Li Y, Guan Y and Wang J: Elevated levels of granzyme B correlated with miR-874-3p downregulation in patients with acute myocardial infarction. Biomark Med. 11:761–767. 2017. View Article : Google Scholar : PubMed/NCBI

4 

Yang F, Liu W, Yan X, Zhou H, Zhang H, Liu J, Yu M, Zhu X and Ma K: Effects of mir-21 on cardiac microvascular endothelial cells after acute myocardial infarction in rats: Role of phosphatase and tensin homolog (PTEN)/vascular endothelial growth factor (VEGF) signal pathway. Med Sci Monit. 22:3562–3575. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Yang SY, Wang YQ, Gao HM, Wang B and He Q: The clinical value of circulating miR-99a in plasma of patients with acute myocardial infarction. Eur Rev Med Pharmacol Sci. 20:5193–5197. 2016.PubMed/NCBI

6 

Yuan J, Chen H, Ge D, Xu Y, Xu H, Yang Y, Gu M, Zhou Y, Zhu J, Ge T, et al: Mir-21 promotes cardiac fibrosis after myocardial infarction via targeting Smad7. Cell Physiol Biochem. 42:2207–2219. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Pan LJ, Wang X, Ling Y and Gong H: miR-24 alleviates cardiomyocyte apoptosis after myocardial infarction via targeting BIM. Eur Rev Med Pharmacol Sci. 21:3088–3097. 2017.PubMed/NCBI

8 

Maciejak A, Kiliszek M, Opolski G, Segiet A, Matlak K, Dobrzycki S, Tulacz D, Sygitowicz G, Burzynska B and Gora M: miR-22-5p revealed as a potential biomarker involved in the acute phase of myocardial infarction via profiling of circulating microRNAs. Mol Med Rep. 14:2867–2875. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ and Sen CK: MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res. 82:21–29. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Li X, Hu H, Wang Y, Xue M, Li X, Cheng W, Xuan Y, Yin J, Yang N and Yan S: Valsartan ameliorates KIR2.1 in rats with myocardial infarction via the NF-κB-miR-16 pathway. Gene. 590:201–209. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Li Y and Maegdefessel L: My heart will go on-beneficial effects of anti-miR-30 after myocardial infarction. Ann Transl Med. 4:1442016. View Article : Google Scholar : PubMed/NCBI

12 

Zhu WS, Guo W, Zhu JN, Tang CM, Fu YH, Lin QX, Tan N and Shan ZX: Hsp90aa1: A novel target gene of miR-1 in cardiac ischemia/reperfusion injury. Sci Rep. 6:244982016. View Article : Google Scholar : PubMed/NCBI

13 

Gao CK, Liu H, Cui CJ, Liang ZG, Yao H and Tian Y: Roles of MicroRNA-195 in cardiomyocyte apoptosis induced by myocardial ischemia-reperfusion injury. J Genet. 95:99–108. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Liu Z, Yang D, Xie P, Ren G, Sun G, Zeng X and Sun X: miR-106b and miR-15b modulate apoptosis and angiogenesis in myocardial infarction. Cell Physiol Biochem. 29:851–862. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Kaija H, Pakanen L and Porvari K: RNU6B, a frequent reference in miRNA expression studies, differentiates between deaths caused by hypothermia and chronic cardiac ischemia. Int J Legal Med. 2019. View Article : Google Scholar : PubMed/NCBI

16 

Zhou Y, Chen Q, Lew KS, Richards AM and Wang P: Discovery of potential therapeutic miRNA targets in cardiac ischemia-reperfusion injury. J Cardiovasc Pharmacol Ther. 21:296–309. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Tu Y, Wan L, Fan Y, Wang K, Bu L, Huang T, Cheng Z and Shen B: Ischemic postconditioning-mediated miRNA-21 protects against cardiac ischemia/reperfusion injury via PTEN/Akt pathway. PLoS One. 8:e758722013. View Article : Google Scholar : PubMed/NCBI

18 

Luo Y, Dong HY, Zhang B, Feng Z, Liu Y, Gao YQ, Dong MQ and Li ZC: miR-29a-3p attenuates hypoxic pulmonary hypertension by inhibiting pulmonary adventitial fibroblast activation. Hypertension. 65:414–420. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Thygesen K, Alpert JS and White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, : Universal definition of myocardial infarction. Eur Heart J. 28:2525–2538. 2007. View Article : Google Scholar : PubMed/NCBI

20 

Chen L, Ji Q, Zhu H, Ren Y, Fan Z and Tian N: miR-30a attenuates cardiac fibrosis in rats with myocardial infarction by inhibiting CTGF. Exp Ther Med. 15:4318–4324. 2018.PubMed/NCBI

21 

Parameswaran S, Santhakumar R, Vidyasekar P and Verma RS: Enrichment of cardiomyocytes in primary cultures of murine neonatal hearts. Methods Mol Biol. 1299:17–25. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Cittadini A, Strömer H, Katz SE, Clark R, Moses AC, Morgan JP and Douglas PS: Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation. 93:800–809. 1996. View Article : Google Scholar : PubMed/NCBI

24 

Xie Q, Sun Z, Chen M, Zhong Q, Yang T and Yi J: IL-8 up-regulates proliferative angiogenesis in ischemic myocardium in rabbits through phosphorylation of Akt/GSK-3β(ser9) dependent pathways. Int J Clin Exp Med. 8:12498–12508. 2015.PubMed/NCBI

25 

Li T, Chen L, Yu Y, Yang B, Li P and Tan XQ: Resveratrol alleviates hypoxia/reoxygenation injury-induced mitochondrial oxidative stress in cardiomyocytes. Mol Med Rep. 19:2774–2780. 2019.PubMed/NCBI

26 

Wang L, Niu X, Hu J, Xing H, Sun M, Wang J, Jian Q and Yang H: After myocardial ischemia-reperfusion, miR-29a, and Let7 could affect apoptosis through regulating IGF-1. Biomed Res Int. 2015:2454122015. View Article : Google Scholar : PubMed/NCBI

27 

Joshi S, Wei J and Bishopric NH: A cardiac myocyte-restricted Lin28/let-7 regulatory axis promotes hypoxia-mediated apoptosis by inducing the AKT signaling suppressor PIK3IP1. Biochim Biophys Acta. 1862:240–251. 2016. View Article : Google Scholar : PubMed/NCBI

28 

Lu C, Wang X, Ha T, Hu Y, Liu L, Zhang X, Yu H, Miao J, Kao R, Kalbfleisch J, et al: Attenuation of cardiac dysfunction and remodeling of myocardial infarction by microRNA-130a are mediated by suppression of PTEN and activation of PI3K dependent signaling. J Mol Cell Cardiol. 89:87–97. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Xu J, Qian J, Xie X, Lin L, Zou Y, Fu M, Huang Z, Zhang G, Su Y and Ge J: High density lipoprotein protects mesenchymal stem cells from oxidative stress-induced apoptosis via activation of the PI3K/Akt pathway and suppression of reactive oxygen species. Int J Mol Sci. 13:17104–17120. 2012. View Article : Google Scholar : PubMed/NCBI

30 

Muzi-Filho H, Bezerra CG, Souza AM, Boldrini LC, Takiya CM, Oliveira FL, Nesi RT, Valença SS, Einicker-Lamas M, Vieyra A, et al: Undernutrition affects cell survival, oxidative stress, Ca2+ handling and signaling pathways in vas deferens, crippling reproductive capacity. PLoS One. 8:e696822013. View Article : Google Scholar : PubMed/NCBI

31 

Liu Z, Li Z and Liu X: Effect of ginsenoside Re on cardiomyocyte apoptosis and expression of Bcl-2/Bax gene after ischemia and reperfusion in rats. J Huazhong Univ Sci Technolog Med Sci. 22:305–309. 2002. View Article : Google Scholar : PubMed/NCBI

32 

Tian Y, Zhang W, Xia D, Modi P, Liang D and Wei M: Postconditioning inhibits myocardial apoptosis during prolonged reperfusion via a JAK2-STAT3-Bcl-2 pathway. J Biomed Sci. 18:532011. View Article : Google Scholar : PubMed/NCBI

33 

Khan M, Meduru S, Mostafa M, Khan S, Hideg K and Kuppusamy P: Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling. J Pharmacol Exp Ther. 333:421–429. 2010. View Article : Google Scholar : PubMed/NCBI

34 

Wang KJ, Zhao X, Liu YZ, Zeng QT, Mao XB, Li SN, Zhang M, Jiang C, Zhou Y, Qian C, et al: Circulating miR-19b-3p, miR-134-5p and miR-186-5p are promising novel biomarkers for early diagnosis of acute myocardial infarction. Cell Physiol Biochem. 38:1015–1029. 2016. View Article : Google Scholar : PubMed/NCBI

35 

Wienbergen H, Schiele R, Gitt AK, Schneider S, Heer T, Gottwik M, Gieseler U, Weber MA, Müller CH, Neubaur J, et al: Incidence, risk factors, and clinical outcome of stroke after acute myocardial infarction in clinical practice. MIR and MITRA Study Groups. Myocardial Infarction Registry. Maximal Individual Therapy in Acute Myocardial Infarction. Am J Cardiol. 87:782–785, A8. 2001. View Article : Google Scholar : PubMed/NCBI

36 

Xin Y, Yang C and Han Z: Circulating miR-499 as a potential biomarker for acute myocardial infarction. Ann Transl Med. 4:1352016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang L, Zhang J, Tong Q, Wang G, Dong H, Wang Z, Sun Q and Wu H: Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax Retraction in /10.3892/etm.2024.12771. Exp Ther Med 18: 1729-1737, 2019.
APA
Zhang, L., Zhang, J., Tong, Q., Wang, G., Dong, H., Wang, Z. ... Wu, H. (2019). Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax Retraction in /10.3892/etm.2024.12771. Experimental and Therapeutic Medicine, 18, 1729-1737. https://doi.org/10.3892/etm.2019.7722
MLA
Zhang, L., Zhang, J., Tong, Q., Wang, G., Dong, H., Wang, Z., Sun, Q., Wu, H."Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax Retraction in /10.3892/etm.2024.12771". Experimental and Therapeutic Medicine 18.3 (2019): 1729-1737.
Chicago
Zhang, L., Zhang, J., Tong, Q., Wang, G., Dong, H., Wang, Z., Sun, Q., Wu, H."Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax Retraction in /10.3892/etm.2024.12771". Experimental and Therapeutic Medicine 18, no. 3 (2019): 1729-1737. https://doi.org/10.3892/etm.2019.7722
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang L, Zhang J, Tong Q, Wang G, Dong H, Wang Z, Sun Q and Wu H: Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax Retraction in /10.3892/etm.2024.12771. Exp Ther Med 18: 1729-1737, 2019.
APA
Zhang, L., Zhang, J., Tong, Q., Wang, G., Dong, H., Wang, Z. ... Wu, H. (2019). Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax Retraction in /10.3892/etm.2024.12771. Experimental and Therapeutic Medicine, 18, 1729-1737. https://doi.org/10.3892/etm.2019.7722
MLA
Zhang, L., Zhang, J., Tong, Q., Wang, G., Dong, H., Wang, Z., Sun, Q., Wu, H."Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax Retraction in /10.3892/etm.2024.12771". Experimental and Therapeutic Medicine 18.3 (2019): 1729-1737.
Chicago
Zhang, L., Zhang, J., Tong, Q., Wang, G., Dong, H., Wang, Z., Sun, Q., Wu, H."Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax Retraction in /10.3892/etm.2024.12771". Experimental and Therapeutic Medicine 18, no. 3 (2019): 1729-1737. https://doi.org/10.3892/etm.2019.7722
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team